TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib
Kung Chu Ho, Yu Hua Dean Fang, Hsiao Wen Chung, Yuan Chang Liu, John Wen Cheng Chang, Ming Mo Hou, Cheng Ta Yang, Nai Ming Cheng, Tzu Pei Su, Tzu Chen Yen*
Research output: Contribution to journal › Journal Article › peer-review
24Scopus
citations
Fingerprint
Dive into the research topics of 'TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib'. Together they form a unique fingerprint.